KABIVEN IN PLASTIC CONTAINER Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Kabiven In Plastic Container, and when can generic versions of Kabiven In Plastic Container launch?
Kabiven In Plastic Container is a drug marketed by Fresenius Kabi Usa and is included in one NDA.
The generic ingredient in KABIVEN IN PLASTIC CONTAINER is amino acids; calcium chloride; dextrose; magnesium sulfate; potassium chloride; sodium acetate; sodium glycerophosphate; soybean oil. There are three hundred and fifty drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the amino acids; calcium chloride; dextrose; magnesium sulfate; potassium chloride; sodium acetate; sodium glycerophosphate; soybean oil profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for KABIVEN IN PLASTIC CONTAINER?
- What are the global sales for KABIVEN IN PLASTIC CONTAINER?
- What is Average Wholesale Price for KABIVEN IN PLASTIC CONTAINER?
Summary for KABIVEN IN PLASTIC CONTAINER
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Clinical Trials: | 2 |
DailyMed Link: | KABIVEN IN PLASTIC CONTAINER at DailyMed |
Recent Clinical Trials for KABIVEN IN PLASTIC CONTAINER
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Fresenius Kabi | Phase 4 |
Wuhan TongJi Hospital | Phase 4 |
Beijing 301 hospital | Phase 4 |